For informational purposes only — not investment advice

← Back to signals

VGNT

LONGINSIDER SELL

VERSIGENT PLC

Research: Finviz ↗·Perplexity ↗

🗄 Viewing archived Q2 2026 data — frozen, no longer refreshed.

Funds
3
Score
3.64
vs SPY
-1.1%
Stock return (since Q-end)
-1.8%
SPY return (since Q-end)
-0.7%
Current price
$41.14
Days to cover (short int.)
3.0d↓-35.3%
as of 2026-09-30 · shares short vs 2026-06-30

News Summary

Positive

Versigent delivered a solid Q3 2026 earnings beat ($1.91 EPS vs. $1.78 consensus) with 9% revenue growth and raised full-year guidance, demonstrating strong execution post-IPO. However, the stock declined 3.3% on the news, suggesting market concerns about valuation or regional headwinds (EMEA weakness, Americas flattish growth) despite analyst maintained bullish ratings with 32% upside potential.

Red flags

  • •EMEA revenue declined 8% on adjusted basis due to softer demand and production shifts
  • •Americas region showed only 1% adjusted growth despite significant launch activity
  • •Stock price fell 3.3% following earnings beat and guidance raise, suggesting investor caution on valuation
  • •High Voltage Electrical Architecture revenue declined 1.2% year-over-year, indicating mixed product line momentum

Funds Buying (3)

FundManagerShares Held∆ SharesPosition Value% of FundQoQStatus
Greenlight CapitalDavid Einhorn2.3M+2.3M$96M2.4%—NEW
Soros Fund ManagementSoros Family Office584K+584K$25M0.3%—NEW
Point72Steve Cohen232K+232K$10M<0.1%—NEW

Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.

Portfolio Context

Where VGNT ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.

Greenlight Capital

position #13 of this fund's book

  1. 10GRAPHIC PACKAGING HLDG CO$105M
  2. 11TD SYNNEX CORPORATION$102M
  3. 12TEVA PHARMACEUTICAL INDS LTD$98M
  4. 13VERSIGENT PLC$96M
  5. 14CAPRI HOLDINGS LIMITED$90M
  6. 15BKV CORP$85M
  7. 16DHT HOLDINGS INC$83M

Values are quarter-end position sizes. Shown only for funds where VGNT ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.

Insider Activity

NameTitleTypeSharesPriceValueFiledSrc
CLARK KEVIN P—SELL45K$44.33$2.00M2026-10-08↗
CLARK KEVIN P—SELL3K$44.88$0.12M2026-10-08↗
CLARK KEVIN P—SELL44K$44.90$1.96M2026-10-07↗
CLARK KEVIN P—SELL5K$45.68$0.24M2026-10-07↗
CLARK KEVIN P—SELL494$46.43$0.02M2026-10-07↗
CLARK KEVIN P—SELL105$47.08$0.00M2026-09-09↗
CLARK KEVIN P—SELL58K$45.49$2.62M2026-09-09↗
CLARK KEVIN P—SELL17K$46.27$0.76M2026-09-09↗
CLARK KEVIN P—SELL38K$47.85$1.83M2026-09-08↗
CLARK KEVIN P—SELL9K$48.50$0.44M2026-09-08↗
CLARK KEVIN P—SELL1K$49.67$0.06M2026-09-08↗

Beneficial Ownership (13D/13G)

FilerFormShares% of ClassFiledSrc
Vanguard Portfolio ManagementSC 13G4.3M6.0%2026-07-31↗
Vanguard Capital ManagementSC 13G3.9M5.5%2026-07-31↗
BlackRock, Inc.SC 13G/A10.6M15.0%2026-07-30↗
BlackRock, Inc.SC 13G8.1M11.4%2026-05-06↗

SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.